Compound Detail
CHEMBL20210
RUPINTRIVIR 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1
Basic Information
| ChEMBL ID | CHEMBL20210 |
| Name | RUPINTRIVIR |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | CAYJBRBGZBCZKO-BHGBQCOSSA-N |
16
Targets
74
Activities
2
Assay Types
10
PK Parameters
20
Publications
3
Known Names
Molecular Properties
598.7
MW (Da)
2.82
ALogP
8
HBA
3
HBD
156.7
PSA (Ų)
0.21
QED
1
Ro5 Violations
15
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Activity Summary
EC50 68 meas. best 8.7
IC50 6 meas. best 7.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| rhinovirus A16 CHEMBL613769 | EC50 | 8.7 | 7.6257 | 2.0 | 7 |
| Human rhinovirus A protease CHEMBL2857 | EC50 | 8.3 | 8.3 | 5.0 | 2 |
| HeLa CHEMBL399 | EC50 | 8.3 | 8.3 | 5.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 8.25 | 8.05 | 5.7 | 2 |
| Enterovirus A71 CHEMBL612436 | EC50 | 8.05 | 7.838 | 9.0 | 5 |
| rhinovirus A2 CHEMBL612678 | EC50 | 7.92 | 7.3614 | 12.0 | 7 |
| rhinovirus B14 CHEMBL613759 | EC50 | 7.89 | 7.1147 | 13.0 | 15 |
| Echovirus E9 CHEMBL613552 | EC50 | 7.82 | 7.82 | 15.0 | 1 |
| Human rhinovirus sp. CHEMBL612470 | EC50 | 7.72 | 7.505 | 19.0 | 2 |
| Human rhinovirus A protease CHEMBL2857 | IC50 | 7.64 | 7.64 | 23.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 7.64 | 7.64 | 23.0 | 1 |
| rhinovirus A39 CHEMBL612527 | EC50 | 7.62 | 7.2433 | 24.0 | 3 |
| Echovirus E6 CHEMBL612779 | EC50 | 7.37 | 7.37 | 43.0 | 1 |
| rhinovirus A21 CHEMBL612371 | EC50 | 7.02 | 6.555 | 95.0 | 2 |
| Enterovirus CHEMBL613749 | EC50 | 6.57 | 6.1783 | 270.0 | 18 |
| Unchecked CHEMBL612545 | IC50 | 5.8 | 5.6733 | 1600.0 | 3 |
| Enterovirus A71 CHEMBL612436 | IC50 | 5.73 | 5.73 | 1870.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 5.73 | 5.73 | 1870.0 | 1 |
| Coxsackievirus B3 CHEMBL613554 | IC50 | 5.18 | 5.18 | 6600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1.497 | ng.hr.mL-1 | Mus musculus |
| CL | 40.74 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 104.71 | mL.min-1.g-1 | Homo sapiens |
| CL | 150.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| T1/2 | 0.03333 | hr | - |
| T1/2 | 1.0 | hr | Canis lupus familiaris |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | - |
| T1/2 | 1.0 | hr | - |
| T1/2 | 0.5 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17908951 | 10.1128/aac.00905-07 | rhinovirus B14 | 44 |
| 17908951 | 10.1128/aac.00905-07 | rhinovirus A2 | 26 |
| 19015331 | 10.1128/aac.00841-08 | Enterovirus | 18 |
| 17908951 | 10.1128/aac.00905-07 | rhinovirus A39 | 17 |
| 17908951 | 10.1128/aac.00905-07 | Human rhinovirus sp. | 12 |
| 24900468 | 10.1021/ml2002955 | Human rhinovirus sp. | 9 |
| 10197965 | 10.1021/jm9805384 | Human rhinovirus A protease | 6 |
| - | 10.6019/CHEMBL3301361 | ADMET | 4 |
| 10197965 | 10.1021/jm9805384 | ADMET | 4 |
| 38784463 | 10.1039/d3md00686g | rhinovirus A16 | 3 |
| 38389877 | 10.1039/d3md00630a | ADMET | 3 |
| 39032404 | 10.1016/j.ejmech.2024.116690 | ADMET | 3 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4513161 | Pseudomonas aeruginosa | 2 |
| 38389877 | 10.1039/d3md00630a | rhinovirus B14 | 2 |
| 11591501 | 10.1016/s0960-894x(01)00542-x | HeLa | 2 |
| 11591501 | 10.1016/s0960-894x(01)00542-x | Homo sapiens | 2 |
| 31184893 | 10.1021/acs.jmedchem.9b00387 | Enterovirus A71 | 2 |
| 27776325 | 10.1016/j.ejmech.2016.10.019 | Unchecked | 2 |
| 10669559 | 10.1021/jm990412m | Human rhinovirus A protease | 2 |
Data from ChEMBL 36 via Core Engine